Stay updated on CLL1-CD33 cCAR in Hematologic Malignancies Clinical Trial

Sign up to get notified when there's something new on the CLL1-CD33 cCAR in Hematologic Malignancies Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the CLL1-CD33 cCAR in Hematologic Malignancies Clinical Trial page

  1. Check
    7 days ago
    Change Detected
    Summary
    Footer now displays Revision: v3.3.3. The HHS Vulnerability Disclosure link was removed, and Revision: v3.3.2 is no longer shown.
    Difference
    0.1%
    Check dated 2025-12-23T22:06:11.000Z thumbnail image
  2. Check
    14 days ago
    No Change Detected
  3. Check
    21 days ago
    No Change Detected
  4. Check
    35 days ago
    Change Detected
    Summary
    The page now lists Revision: v3.3.2, replacing the previous Revision: v3.2.0.
    Difference
    0.1%
    Check dated 2025-11-25T11:32:24.000Z thumbnail image
  5. Check
    43 days ago
    Change Detected
    Summary
    Removed the notice about potential delays and NIH operating status due to funding lapse. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-18T07:12:59.000Z thumbnail image
  6. Check
    57 days ago
    Change Detected
    Summary
    The new screenshot exhibits the same study details with only minor visual and layout adjustments; no substantive edits to the study content or eligibility criteria were observed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.5%
    Check dated 2025-11-03T20:57:46.000Z thumbnail image
  7. Check
    86 days ago
    Change Detected
    Summary
    - Added a government-operating-status notice and a link to official sources, indicating the page may have dynamic status information. - Updated version from v3.1.0 to v3.2.0, signaling a new release.
    Difference
    5%
    Check dated 2025-10-06T05:23:18.000Z thumbnail image
  8. Check
    93 days ago
    Change Detected
    Summary
    Core content update includes standardizing the term to BCR-ABL1 and upgrading the revision to v3.1.0; additions introduce new identifiers (number and email addresses) with minor relevance to contact-like data.
    Difference
    0.4%
    Check dated 2025-09-29T03:00:58.000Z thumbnail image

Stay in the know with updates to CLL1-CD33 cCAR in Hematologic Malignancies Clinical Trial

Enter your email address, and we'll notify you when there's something new on the CLL1-CD33 cCAR in Hematologic Malignancies Clinical Trial page.